R. Mccullough

发表

Dynamic bone scintigraphy in osteochondritis dissecans

E. Gandsman, R. Mccullough, H. Litchman, 2004, International Orthopaedics.

Barrier therapies supporting the biology of the mucosal barrier-medical devices for common clinical mucosal disorders.

R. Mccullough, 2021, Translational gastroenterology and hepatology.

Wide-area transepithelial sampling with computer-assisted 3-dimensional analysis (WATS) markedly improves detection of esophageal dysplasia and Barrett's esophagus: analysis from a prospective multicenter community-based study

S. Dwivedi, V. Kaul, S. Gross, 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Actual duration of patient-reported mucositis: Far longer than 2 to 4 weeks and may be avoidable altogether

R. Mccullough, 2016 .

IBS, NERD and functional dyspepsia are immuno-neuronal disorders of mucosal cytokine imbalances clinically reversible with high potency sucralfate.

R. Mccullough, 2013, Medical hypotheses.

ProThelial™ (Polymerized Cross-Linked High Potency Sucralfate): Medical Device Therapy for Treatment and Prevention of Mucositis

R. Mccullough, 2014 .

A 66 patient multi-institution phase IV post-authorization surveillance of ProThelialTM (high potency polymerized cross-linked sucralfate) - single agent efficacy for the prevention and rapid reversal of chemo-radiation induced oral, esophageal and intestinal mucositis.

R. Mccullough, 2015 .

Unprecedented Simultaneous and Rapid Reversal of Oral and Alimentary Mucositis using Polymerized Cross Linked Sucralfate: Two Case Reports

R. Mccullough, 2014 .

Expedited management of ulcer, colic and diarrhea in 209 horses: An open-labeled observational study of a potency-enhanced sucralfate-like elm phyto-saccharide

R. Mccullough, 2013 .

The Role for Pre-Polymerized Sucralfate in Management of Erosive and Non-Erosive Gastroesophageal Reflux Disease – High Potency Sucralfate-Mucin Barrier for Enteric Cytoprotection

R. Mccullough, 2020, Academic Journal of Gastroenterology & Hepatology.

GASTRONTESTINAL ANT-RRTANT COMPOSITION COMPRISING SUCRALFATE AND METHODS OF USE

R. Mccullough, 2017 .

7 Day Comparative Effectiveness in Heartburn Relief and Endoscopic Healing. Randomized Controlled Trial using Omeprazole, Ranitidine, Antacids and Esolgafate, A Pre-Polymerized Cross-Linked Sucralfate (PCLS) Barrier Therapy

R. Mccullough, 2020, Academic Journal of Gastroenterology & Hepatology.

US oncology-wide incidence, duration, costs and deaths from chemoradiation mucositis and antimucositis therapy benefits.

R. Mccullough, 2017, Future oncology.

Practice insights on patient care—management overview for chemoradiation toxic mucositis—guidelines, guideline-supported therapies and high potency polymerized cross-linked sucralfate (ProThelial)

R. Mccullough, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Dynamic bone imaging in the differential diagnosis of skeletal lesions.

E. Gandsman, R. Mccullough, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Computerized blood flow analysis for decision making in the treatment of osteochondritis dissecans.

H. Litchman, E. Gandsman, R. Mccullough, 1988, Journal of pediatric orthopedics.

Outsized Treatment Effects of High Potency Polymerized Cross-Linked Sucralfate (ProThelial) for Oral and Gastrointestinal Chemoradiation Mucositis The Level of Evidence and Implication for National Cancer Center Network Category 2A Recommendations

R. Mccullough, 2018 .

Complete prevention and rapid sustained elimination of chemoradiation toxic mucositis, a case series with implications for mucositis pathobiology, cost of care, morbidity and premature cancer deaths

R. Mccullough, 2017 .

Deciphering the pathophysiology of irritable bowel syndrome and functional gastrointestinal disorders-an alternative model for pathogenesis: cytokine controlled transepithelial multi-feedback loop.

R. Mccullough, Jeremiah McCullough, 2017, Translational gastroenterology and hepatology.

Expedited Management of Canine and Feline Vomiting and Diarrhea. Observational Study in 3952 Dogs and 2248 Cats Using Sucralfate-Like Potency-Enhanced Polyanionic Phyto-Saccharide—Elm Mucilage

R. Mccullough, 2013 .

Elimination of unplanned treatment breaks and dose reductions caused by mucositis: Positive implications for survival outcomes and cost reductions using high potency polymerized cross-linked sucralfate in 55 patients undergoing radiation for head and neck cancer with and without chemotherapy

R. Mccullough, 2017 .

Efficacy and Safety of Esolgafate, A Pre-Polymerized Cross-Linked Sucralfate Medical Device for NERD. A Randomized Double-Blind Placebo-Controlled Trial

R. Mccullough, 2020, Academic Journal of Gastroenterology & Hepatology.

High-potency sucralfate prevents and rapidly reverses chemo-radiation mucositis in a patient with stage 4b head and neck cancer

R. Mccullough, 2013 .

28 Day Randomized Double-Blind Placebo Controlled Trial using Pre-Polymerized Cross-Linked Sucralfate Barrier (Esolgafate) for Erosive GERD

R. Mccullough, 2020, Academic Journal of Gastroenterology & Hepatology.